Pharmacokinetics, Safety and Antiviral Activity of Fosamprenavir/Ritonavir-containing Regimens in HIV-infected Children Aged 4 Weeks to 2 Years—48-week Study Data

BACKGROUND: Pharmacokinetics, safety and antiviral activity of fosamprenavir (FPV) with ritonavir (RTV) twice daily were evaluated in HIV-1–infected infants and children 4 weeks to <2 years over 48 weeks. METHODS: Results from intensive pharmacokinetic sampling of subjects enrolled in single dose...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Cotton, Mark, Cassim, Haseena, Pavía-Ruz, Noris, Garges, Harmony P., Perger, Teodora, Ford, Susan L., Wire, Mary Beth, Givens, Naomi, Ross, Lisa L., Lou, Yu, Sievers, Jörg, Cheng, Katharine
Médium: Artigo
Jazyk:Inglês
Vydáno: Williams & Wilkins 2014
Témata:
HIV Reports
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3882303/
https://ncbi.nlm.nih.gov/pubmed/23811743
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/INF.0b013e3182a1123a
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky